MOCS2 catalyzes the second step of the conserved molybdenum cofactor biosynthesis pathway, converting precursor Z to molybdopterin (MPT) as the molybdopterin synthase enzyme (PMID:12754701, PMID:16737835, PMID:40707723). The gene has a bicistronic architecture, encoding two distinct proteins in overlapping reading frames — the small sulfur-carrier subunit MOCS2A and the large catalytic subunit MOCS2B — expressed either from alternatively spliced mRNAs or by independent translation of a bicistronic transcript (PMID:12754701, PMID:16737835). The two subunits assemble into an obligate heterodimeric complex: the C-terminus of MOCS2B mediates binding to both the precursor Z substrate and to MOCS2A, and a mutation eliminating the MOCS2B stop codon abolishes both interactions (PMID:16021469), while MOCS2B protein is degraded in the absence of MOCS2A, establishing co-dependence of the subunits for stability (PMID:16737835). A single nucleotide change disrupting both reading frames reduces MPT synthase complex formation and enzymatic activity, confirming that intact subunit assembly is required for catalysis (PMID:40707723). The conserved sulfur-carrier role of the MOCS2A subunit in endogenous molybdenum cofactor synthesis has been validated genetically in the C. elegans ortholog moc-6 (PMID:35224462).